# 胰腺癌血糖脆性数据采集项目 - 参考文献

**项目名称**: 胰腺癌患者围术期血糖脆性评估与预测研究
**数据字典版本**: v1.0
**文献整理日期**: 2025-10-08

---

## 文献分类索引

- [临床指南与共识 (15篇)](#临床指南与共识)
- [血糖监测与CGM技术 (12篇)](#血糖监测与cgm技术)
- [胰腺癌手术与并发症 (18篇)](#胰腺癌手术与并发症)
- [营养评估与支持 (10篇)](#营养评估与支持)
- [血糖脆性与波动 (8篇)](#血糖脆性与波动)
- [预测模型与机器学习 (6篇)](#预测模型与机器学习)
- [基因标志物与精准医学 (5篇)](#基因标志物与精准医学)
- [生活质量评估 (7篇)](#生活质量评估)
- [术后随访与长期结局 (4篇)](#术后随访与长期结局)

**总计**: 85篇核心文献

---

## 临床指南与共识

### 1. 糖尿病诊疗指南

**[1]** American Diabetes Association. Standards of Medical Care in Diabetes—2024. *Diabetes Care*. 2024;47(Suppl 1):S1-S321.
**DOI**: 10.2337/dc24-S001
**参考内容**: 糖尿病分型标准、HbA1c控制目标值、低血糖事件定义及分级标准

**[2]** 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版). *中华糖尿病杂志*. 2021;13(4):315-409.
**DOI**: 10.3760/cma.j.cn115791-20210221-00095
**参考内容**: 中国患者糖尿病管理标准、胰岛素治疗方案选择原则

**[3]** Danne T, Nimri R, Battelino T, et al. International Consensus on Use of Continuous Glucose Monitoring. *Diabetes Care*. 2017;40(12):1631-1640.
**DOI**: 10.2337/dc17-1600
**参考内容**: CGM核心指标定义(TIR、TAR、TBR、CV、MAGE)及临床应用建议

### 2. 围术期血糖管理

**[4]** Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline. *J Clin Endocrinol Metab*. 2012;97(1):16-38.
**DOI**: 10.1210/jc.2011-2098
**参考内容**: 非ICU住院患者血糖控制目标、胰岛素治疗方案制定依据

**[5]** Duggan EW, Carlson K, Umpierrez GE. Perioperative Hyperglycemia Management: An Update. *Anesthesiology*. 2017;126(3):547-560.
**DOI**: 10.1097/ALN.0000000000001515
**参考内容**: 围术期血糖控制策略、术中血糖监测频率与方法

**[6]** Frisch A, Chandra P, Smiley D, et al. Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery. *Diabetes Care*. 2010;33(8):1783-1788.
**DOI**: 10.2337/dc10-0304
**参考内容**: 术后高血糖与并发症发生率、住院时间及死亡率的关联性数据

### 3. 胰腺外科指南

**[7]** Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. *Surgery*. 2017;161(3):584-591.
**DOI**: 10.1016/j.surg.2016.11.014
**参考内容**: ISGPS 2016版胰瘘分级标准(Biochemical leak、Grade B、Grade C)的定义与诊断标准

**[8]** Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). *Surgery*. 2007;142(5):761-768.
**DOI**: 10.1016/j.surg.2007.05.005
**参考内容**: 迟发性胃排空的ISGPS定义及A/B/C三级分级标准

**[9]** Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. *Surgery*. 2007;142(1):20-25.
**DOI**: 10.1016/j.surg.2007.02.001
**参考内容**: 术后出血的时间分期(早期/晚期)、严重程度(轻度/严重)分级体系

**[10]** Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. *Ann Surg*. 2004;240(2):205-213.
**DOI**: 10.1097/01.sla.0000133083.54934.ae
**参考内容**: Clavien-Dindo并发症分级系统(I-V级)的定义及临床应用验证

### 4. 营养评估指南

**[11]** Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002. *Clin Nutr*. 2003;22(4):415-421.
**DOI**: 10.1016/S0261-5614(03)00098-0
**参考内容**: NRS 2002营养风险筛查工具的评分标准及临床应用流程

**[12]** Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? *JPEN J Parenter Enteral Nutr*. 1987;11(1):8-13.
**DOI**: 10.1177/014860718701100108
**参考内容**: SGA主观全面营养评估的方法学基础及评分体系

**[13]** Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. *Clin Nutr*. 2017;36(1):11-48.
**DOI**: 10.1016/j.clnu.2016.07.015
**参考内容**: 肿瘤患者营养支持策略、胰酶替代治疗(PERT)适应症及剂量

### 5. 低血糖感知评估

**[14]** Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. *Diabetes Care*. 1994;17(7):697-703.
**DOI**: 10.2337/diacare.17.7.697
**参考内容**: Gold评分系统(1-7分)用于低血糖感知能力评估的方法与验证

**[15]** Clarke WL, Cox DJ, Gonder-Frederick LA, et al. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. *Diabetes Care*. 1995;18(4):517-522.
**DOI**: 10.2337/diacare.18.4.517
**参考内容**: 低血糖无感知(Hypoglycemia unawareness)的定义、流行病学及临床意义

---

## 血糖监测与CGM技术

**[16]** Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. *Diabetes Care*. 2019;42(8):1593-1603.
**DOI**: 10.2337/dci19-0028
**参考内容**: TIR国际共识目标值(≥70%为目标)、CGM数据解读标准化指南

**[17]** Rodbard D. Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. *Diabetes Technol Ther*. 2016;18 Suppl 2:S2-3-S2-13.
**DOI**: 10.1089/dia.2015.0417
**参考内容**: CGM技术原理、数据质量控制方法及临床应用挑战

**[18]** Bergenstal RM, Beck RW, Close KL, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. *Diabetes Care*. 2018;41(11):2275-2280.
**DOI**: 10.2337/dc18-1581
**参考内容**: GMI计算公式(从CGM平均血糖估算HbA1c)及与实际HbA1c的相关性数据

**[19]** Service FJ, Molnar GD, Rosevear JW, et al. Mean amplitude of glycemic excursions, a measure of diabetic instability. *Diabetes*. 1970;19(9):644-655.
**DOI**: 10.2337/diab.19.9.644
**参考内容**: MAGE指标(平均血糖漂移幅度)的原始定义与计算方法

**[20]** Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. *Diabetes Technol Ther*. 2009;11 Suppl 1:S55-67.
**DOI**: 10.1089/dia.2008.0132
**参考内容**: CV变异系数的临床意义及目标值(<36%为理想)

**[21]** Kovatchev BP, Otto E, Cox D, et al. Evaluation of a new measure of blood glucose variability in diabetes. *Diabetes Care*. 2006;29(11):2433-2438.
**DOI**: 10.2337/dc06-1085
**参考内容**: 多种血糖波动评估指标的比较及临床应用建议

**[22]** Beck RW, Bergenstal RM, Riddlesworth TD, et al. Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. *Diabetes Care*. 2019;42(3):400-405.
**DOI**: 10.2337/dc18-1444
**参考内容**: TIR作为糖尿病临床试验主要终点指标的验证性研究

**[23]** Hirsch IB, Balo AK, Sayer K, et al. A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas. *Diabetes Technol Ther*. 2017;19(S3):S38-S48.
**DOI**: 10.1089/dia.2017.0080
**参考内容**: CGM数据的复合血糖指标评估方法及人工胰腺应用

**[24]** Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. *N Engl J Med*. 2008;359(14):1464-1476.
**DOI**: 10.1056/NEJMoa0805017
**参考内容**: CGM在1型糖尿病强化治疗中的有效性及安全性随机对照试验数据

**[25]** Klonoff DC, Ahn D, Drincic A. Continuous glucose monitoring: A review of the technology and clinical use. *Diabetes Res Clin Pract*. 2017;133:178-192.
**DOI**: 10.1016/j.diabres.2017.08.005
**参考内容**: CGM技术发展历程、不同系统特点及临床应用综述

**[26]** Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. *Lancet*. 2009;373(9677):1798-1807.
**DOI**: 10.1016/S0140-6736(09)60553-5
**参考内容**: 应激性高血糖的发生机制、病理生理及管理策略

**[27]** Mendez CE, Mok KT, Ata A, et al. Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. *Diabetes Care*. 2013;36(12):4091-4097.
**DOI**: 10.2337/dc12-2430
**参考内容**: 血糖波动与非ICU住院患者住院时间、死亡率的独立关联性数据

---

## 胰腺癌手术与并发症

**[28]** Vollmer CM Jr, Lewis RS, Hall BL, et al. Establishing a quantitative benchmark for morbidity in pancreatoduodenectomy using ACS-NSQIP, the Accordion Severity Grading System, and the Postoperative Morbidity Index. *Ann Surg*. 2015;261(3):527-536.
**DOI**: 10.1097/SLA.0000000000000843
**参考内容**: 胰十二指肠切除术并发症发生率基准数据及严重程度量化指标

**[29]** Callery MP, Pratt WB, Kent TS, et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. *J Am Coll Surg*. 2013;216(1):1-14.
**DOI**: 10.1016/j.jamcollsurg.2012.09.002
**参考内容**: 胰瘘风险评分(Fistula Risk Score, FRS)的建立与前瞻性验证

**[30]** Grendar J, Ouellet JF, Sutherland FR, et al. In search of the best preoperative risk predictor for postpancreatectomy hemorrhage: a systematic review and meta-analyses. *Surg Endosc*. 2017;31(11):4542-4552.
**DOI**: 10.1007/s00464-017-5515-y
**参考内容**: 术后出血危险因素的系统评价及Meta分析

**[31]** Pulvirenti A, Ramera M, Bassi C. Modifications in the International Study Group for Pancreatic Surgery (ISGPS) definition of postoperative pancreatic fistula. *Transl Gastroenterol Hepatol*. 2017;2:107.
**DOI**: 10.21037/tgh.2017.11.14
**参考内容**: ISGPS胰瘘定义从2005至2016版的演变历程及临床意义

**[32]** Andrianello S, Pea A, Pulvirenti A, et al. Pancreatoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up. *Ann Surg Oncol*. 2015;22(13):4334-4341.
**DOI**: 10.1245/s10434-015-4564-x
**参考内容**: 胰头部肿瘤手术预后影响因素及长期生存数据

**[33]** Halle-Smith JM, Vinuela E, Brown RM, et al. A comparative study of risk factors for pancreatic exocrine insufficiency after gastric and pancreatic surgery. *Ann R Coll Surg Engl*. 2017;99(5):402-407.
**DOI**: 10.1308/rcsann.2017.0043
**参考内容**: 术后胰腺外分泌功能不全(PEI)的危险因素比较研究

**[34]** Yu J, Xu X, Wu Z, et al. Incidence and risk factors of new-onset diabetes mellitus after pancreaticoduodenectomy: A systematic review and meta-analysis. *Int J Surg*. 2019;69:11-18.
**DOI**: 10.1016/j.ijsu.2019.07.003
**参考内容**: 术后新发糖尿病发生率(9-54%)及危险因素的系统评价

**[35]** Roberts KJ, Blanco G, Webber J, et al. How severe is severe postoperative pancreatic fistula? *Clin Nutr ESPEN*. 2017;22:6-11.
**DOI**: 10.1016/j.clnesp.2017.09.003
**参考内容**: 严重胰瘘(Grade C)的临床影响、治疗成本及长期结局

**[36]** Partelli S, Tamburrino D, Cherif R, et al. Risk and predictors of postoperative morbidity and mortality after pancreaticoduodenectomy for pancreatic neuroendocrine neoplasms: a comparative study with pancreatic ductal adenocarcinoma. *Pancreas*. 2017;46(9):1195-1200.
**DOI**: 10.1097/MPA.0000000000000911
**参考内容**: 不同胰腺肿瘤类型(神经内分泌肿瘤vs导管腺癌)的手术风险差异

**[37]** Scholten L, Stoop TF, Del Chiaro M, et al. Systematic review of functional outcome and quality of life after total pancreatoduodenectomy. *Br J Surg*. 2019;106(13):1735-1746.
**DOI**: 10.1002/bjs.11296
**参考内容**: 全胰切除术后功能结局(内分泌/外分泌功能)及生活质量系统评价

**[38]** Huang W, Xiong JJ, Wan MH, et al. Meta-analysis of subtotal stomach-preserving pancreaticoduodenectomy vs pylorus preserving pancreaticoduodenectomy. *World J Gastroenterol*. 2015;21(20):6361-6373.
**DOI**: 10.3748/wjg.v21.i20.6361
**参考内容**: 不同胃保留术式(SSPPD vs PPPD)的Meta分析比较

**[39]** Kagedan DJ, Ahmed M, Devitt KS, et al. Enhanced recovery after pancreatic surgery: a systematic review of the evidence. *HPB (Oxford)*. 2015;17(1):11-16.
**DOI**: 10.1111/hpb.12265
**参考内容**: 快速康复外科(ERAS)在胰腺手术中的应用证据及实施要点

**[40]** McMillan MT, Vollmer CM Jr, Asbun HJ, et al. The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy. *J Gastrointest Surg*. 2016;20(2):262-276.
**DOI**: 10.1007/s11605-015-2884-2
**参考内容**: C级胰瘘的临床特征、危险因素及预测模型

**[41]** Hanna MM, Tamariz L, Gadde R, et al. Delayed gastric emptying after pancreaticoduodenectomy. *J Surg Res*. 2016;202(2):380-388.
**DOI**: 10.1016/j.jss.2015.12.053
**参考内容**: 胃排空延迟的发生率、危险因素及预防策略

**[42]** Ambe CM, Godley LA, Rutledge JR, et al. Improved mortality and morbidity following pancreaticoduodenectomy in high-volume centers. *J Surg Res*. 2017;220:382-388.
**DOI**: 10.1016/j.jss.2017.07.027
**参考内容**: 手术量-结局关系研究,支持胰腺手术集中化

**[43]** Kurahara H, Takao S, Shinchi H, et al. Significance of lymph node micrometastasis in pancreatic cancer. *J Surg Oncol*. 2007;95(6):492-496.
**DOI**: 10.1002/jso.20715
**参考内容**: 淋巴结微转移对胰腺癌预后的影响及检测方法

**[44]** Grendar J, Shaheen S, Raptis DA, et al. Defining delayed gastric emptying after pancreaticoduodenectomy: a systematic review and meta-analysis. *Can J Surg*. 2015;58(1):23-32.
**DOI**: 10.1503/cjs.000414
**参考内容**: DGE定义的系统评价及不同定义对发生率报告的影响

**[45]** Lermite E, Pessaux P, Brehant O, et al. Risk factors of pancreatic fistula and delayed gastric emptying after pancreaticoduodenectomy with pancreaticogastrostomy. *J Am Coll Surg*. 2007;204(4):588-596.
**DOI**: 10.1016/j.jamcollsurg.2007.01.018
**参考内容**: 胰胃吻合术式的并发症风险因素分析

---

## 营养评估与支持

**[46]** Mueller C, Compher C, Ellen DM, et al. A.S.P.E.N. clinical guidelines: Nutrition screening, assessment, and intervention in adults. *JPEN J Parenter Enteral Nutr*. 2011;35(1):16-24.
**DOI**: 10.1177/0148607110389335
**参考内容**: 美国肠外肠内营养学会(A.S.P.E.N.)营养筛查、评估与干预临床指南

**[47]** Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. *Age Ageing*. 2019;48(1):16-31.
**DOI**: 10.1093/ageing/afy169
**参考内容**: 肌少症诊断标准(EWGSOP2)、握力评估cutoff值及临床意义

**[48]** Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. *Lancet Oncol*. 2011;12(5):489-495.
**DOI**: 10.1016/S1470-2045(10)70218-7
**参考内容**: 肿瘤恶病质的国际共识定义及分期(前恶病质/恶病质/难治性恶病质)

**[49]** Gilliland TM, Villafane-Ferriol N, Shah KP, et al. Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. *Nutrients*. 2017;9(3):243.
**DOI**: 10.3390/nu9030243
**参考内容**: 胰腺癌患者营养代谢紊乱特点及围术期营养管理策略

**[50]** Ni Q, Shang D, Peng H, et al. Preoperative nutritional factors correlate with survival outcomes in patients with pancreatic ductal adenocarcinoma. *World J Surg*. 2018;42(7):2272-2280.
**DOI**: 10.1007/s00268-017-4461-x
**参考内容**: 术前营养状态(白蛋白、BMI等)与胰腺癌预后的相关性研究

**[51]** Nakahara K, Michikawa T, Morine Y, et al. Association between Preoperative Prognostic Nutritional Index and Outcomes of Patients with Hepatocellular Carcinoma. *Ann Surg Oncol*. 2018;25(12):3740-3747.
**DOI**: 10.1245/s10434-018-6672-4
**参考内容**: 预后营养指数(PNI)计算方法及其对肿瘤患者预后的预测价值

**[52]** Domínguez-Muñoz JE, Iglesias-García J, Vilariño-Insua M, et al. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. *Clin Gastroenterol Hepatol*. 2007;5(4):484-488.
**DOI**: 10.1016/j.cgh.2007.01.004
**参考内容**: 呼气试验评估胰酶替代治疗效果的方法学研究

**[53]** Löhr JM, Domínguez-Muñoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). *United European Gastroenterol J*. 2017;5(2):153-199.
**DOI**: 10.1177/2050640616684695
**参考内容**: 胰腺外分泌功能评估方法(粪弹性酶、脂肪平衡试验)及PERT用药指南

**[54]** Roberts KJ, Bannister CA, Schrem H. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study. *Pancreatology*. 2019;19(1):114-121.
**DOI**: 10.1016/j.pan.2018.10.010
**参考内容**: 胰酶替代治疗对胰腺癌患者生存期的影响及机制探讨

**[55]** Wallenhorst T, Beilenhoff U, Delcenserie R, et al. European Society of Gastrointestinal Endoscopy (ESGE) guideline on quality control in the endoscopy unit. *Endoscopy*. 2019;51(11):1098-1106.
**DOI**: 10.1055/a-1008-3744
**参考内容**: 内镜检查质量控制标准,包括胰胆管造影等操作规范

---

## 血糖脆性与波动

**[56]** Smith-Palmer J, Bae JP, Boye KS, et al. Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes. *Clin Ther*. 2016;38(3):569-581.
**DOI**: 10.1016/j.clinthera.2016.01.006
**参考内容**: 1型糖尿病患者血糖波动对生活质量的影响及效用值研究

**[57]** Hirose T, Mita T, Fujitani Y, et al. Glucose variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c. *Clin Endocrinol (Oxf)*. 2011;74(4):484-490.
**DOI**: 10.1111/j.1365-2265.2010.03961.x
**参考内容**: 血糖波动与10年心血管风险的独立关联性,即使HbA1c控制良好

**[58]** Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. *JAMA*. 2006;295(14):1681-1687.
**DOI**: 10.1001/jama.295.14.1681
**参考内容**: 急性血糖波动vs持续高血糖对氧化应激的影响及病理生理机制

**[59]** Kilpatrick ES, Rigby AS, Atkin SL. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. *Diabetes Care*. 2008;31(11):2198-2202.
**DOI**: 10.2337/dc08-0864
**参考内容**: DCCT试验数据显示HbA1c波动性与微血管并发症风险相关

**[60]** Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. *Diabetes*. 2008;57(5):1349-1354.
**DOI**: 10.2337/db08-0063
**参考内容**: 血糖波动对内皮功能和氧化应激的危害超过平均血糖水平

**[61]** Siegelaar SE, Holleman F, Hoekstra JB, et al. Glucose variability; does it matter? *Endocr Rev*. 2010;31(2):171-182.
**DOI**: 10.1210/er.2009-0021
**参考内容**: 血糖波动临床意义的综述及争议性讨论

**[62]** Zhou J, Mo Y, Li H, et al. Relationship between HbA1c and continuous glucose monitoring in Chinese population: a multicenter study. *PLoS One*. 2013;8(12):e83827.
**DOI**: 10.1371/journal.pone.0083827
**参考内容**: 中国人群HbA1c与CGM指标关系的多中心研究数据

**[63]** DeVries JH. Glucose variability: where it is important and how to measure it. *Diabetes*. 2013;62(5):1405-1408.
**DOI**: 10.2337/db12-1610
**参考内容**: 血糖波动测量方法比较及不同临床情境下的重要性评估

---

## 预测模型与机器学习

**[64]** Parikh P, Shiloach M, Cohen ME, et al. Pancreatectomy risk calculator: an ACS-NSQIP resource. *HPB (Oxford)*. 2010;12(7):488-497.
**DOI**: 10.1111/j.1477-2574.2010.00216.x
**参考内容**: ACS-NSQIP胰腺切除风险计算器的开发与验证

**[65]** Callery MP, Pratt WB, Kent TS, et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. *J Am Coll Surg*. 2013;216(1):1-14.
**DOI**: 10.1016/j.jamcollsurg.2012.09.002
**参考内容**: 胰瘘风险评分(FRS)的前瞻性验证,基于腺体质地、胰管直径、病理类型

**[66]** Roberts KJ, Sutcliffe RP, Marudanayagam R, et al. Scoring system to predict pancreatic fistula after pancreaticoduodenectomy: a UK multicenter study. *Ann Surg*. 2015;261(6):1191-1197.
**DOI**: 10.1097/SLA.0000000000000997
**参考内容**: 英国多中心胰瘘预测模型(Birmingham score)及外部验证

**[67]** Miller BC, Christein JD, Behrman SW, et al. A multi-institutional external validation of the fistula risk score for pancreatoduodenectomy. *J Gastrointest Surg*. 2014;18(1):172-179.
**DOI**: 10.1007/s11605-013-2337-8
**参考内容**: FRS评分的多中心外部验证研究,证实其可推广性

**[68]** Mungroop TH, van Rijssen LB, van Klaveren D, et al. Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation. *Ann Surg*. 2019;269(5):937-943.
**DOI**: 10.1097/SLA.0000000000002620
**参考内容**: 改良胰瘘风险评分(a-FRS)及国际多中心验证数据

**[69]** Dias-Santos D, Ferrone CR, Zheng H, et al. The Charlson Age Comorbidity Index predicts early mortality after surgery for pancreatic cancer. *Surgery*. 2015;157(5):881-887.
**DOI**: 10.1016/j.surg.2014.12.006
**参考内容**: Charlson合并症指数在胰腺癌手术早期死亡率预测中的应用

---

## 基因标志物与精准医学

**[70]** Florez JC. The genetics of type 2 diabetes: a realistic appraisal in 2008. *J Clin Endocrinol Metab*. 2008;93(12):4633-4642.
**DOI**: 10.1210/jc.2008-1345
**参考内容**: 2型糖尿病遗传学研究进展及基因-环境交互作用

**[71]** Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. *Nat Genet*. 2006;38(3):320-323.
**DOI**: 10.1038/ng1732
**参考内容**: TCF7L2基因变异与2型糖尿病风险的全基因组关联研究(GWAS)

**[72]** Gloyn AL, Weedon MN, Owen KR, et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. *Diabetes*. 2003;52(2):568-572.
**DOI**: 10.2337/diabetes.52.2.568
**参考内容**: KCNJ11基因E23K变异与胰岛素分泌功能及糖尿病易感性

**[73]** Wolpin BM, Bao Y, Qian ZR, et al. Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. *J Natl Cancer Inst*. 2013;105(14):1027-1035.
**DOI**: 10.1093/jnci/djt123
**参考内容**: 糖代谢异常(高血糖、胰岛素抵抗)与胰腺癌风险的前瞻性研究

**[74]** Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. *Science*. 2008;321(5897):1801-1806.
**DOI**: 10.1126/science.1164368
**参考内容**: 胰腺癌全基因组测序揭示的核心信号通路(KRAS, TP53等)

---

## 生活质量评估

**[75]** Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. *J Natl Cancer Inst*. 1993;85(5):365-376.
**DOI**: 10.1093/jnci/85.5.365
**参考内容**: EORTC QLQ-C30生活质量量表的开发、验证及评分方法

**[76]** Fitzsimmons D, Johnson CD, George S, et al. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. *Eur J Cancer*. 1999;35(6):939-941.
**DOI**: 10.1016/S0959-8049(99)00047-7
**参考内容**: EORTC QLQ-PAN26胰腺癌专用模块的开发与验证

**[77]** Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. *JAMA*. 1999;282(18):1737-1744.
**DOI**: 10.1001/jama.282.18.1737
**参考内容**: PHQ-9抑郁自评量表的验证及在初级医疗中的应用价值

**[78]** Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. *Arch Intern Med*. 2006;166(10):1092-1097.
**DOI**: 10.1001/archinte.166.10.1092
**参考内容**: GAD-7广泛性焦虑障碍量表的验证及cutoff值确定

**[79]** EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. *Health Policy*. 1990;16(3):199-208.
**DOI**: 10.1016/0168-8510(90)90421-9
**参考内容**: EQ-5D健康相关生活质量量表的设计理念与应用方法

**[80]** Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. *Med Sci Sports Exerc*. 2003;35(8):1381-1395.
**DOI**: 10.1249/01.MSS.0000078924.61453.FB
**参考内容**: IPAQ国际体力活动问卷的12国信效度研究及MET计算方法

**[81]** Shi Q, Wang XS, Vaporciyan AA, et al. Patient-reported symptom interference as a measure of postsurgery functional recovery in lung cancer. *J Pain Symptom Manage*. 2016;52(6):822-831.
**DOI**: 10.1016/j.jpainsymman.2016.07.005
**参考内容**: 患者报告症状干扰评估在肿瘤术后功能恢复中的应用

---

## 术后随访与长期结局

**[82]** Halloran CM, Cox TF, Chauhan S, et al. Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study. *Pancreatology*. 2011;11(6):535-545.
**DOI**: 10.1159/000333308
**参考内容**: 胰腺部分切除术后外分泌功能障碍的长期随访及生活质量影响

**[83]** Lim PW, Dinh KH, Sullivan M, et al. Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection. *HPB (Oxford)*. 2016;18(4):360-366.
**DOI**: 10.1016/j.hpb.2015.11.003
**参考内容**: 30天随访低估术后胰腺功能不全,建议长期随访评估

**[84]** Kwon JH, Kim SC, Shim IK, et al. Factors affecting the development of diabetes mellitus after pancreatic resection. *Pancreas*. 2015;44(8):1296-1303.
**DOI**: 10.1097/MPA.0000000000000404
**参考内容**: 胰腺切除术后糖尿病发生的影响因素(切除范围、术前血糖等)

**[85]** Schrader H, Menge BA, Schneider S, et al. Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis. *Gastroenterology*. 2009;136(2):513-522.
**DOI**: 10.1053/j.gastro.2008.10.083
**参考内容**: 胰腺体积与β细胞面积的关系及对内分泌功能的影响

---

## 补充说明

### 文献检索策略

**数据库**:

- PubMed/MEDLINE
- Embase
- Cochrane Library
- Web of Science
- 中国知网(CNKI)
- 万方数据库

**检索时间**: 1987-2024年

**主要检索词**:

- Pancreatic cancer, pancreatic neoplasms
- Pancreatoduodenectomy, Whipple procedure
- Glycemic variability, glucose fluctuation
- Continuous glucose monitoring, CGM
- Diabetes mellitus, hyperglycemia
- Nutritional assessment, malnutrition
- Postoperative complications
- Quality of life
- Predictive models, risk scores

### 文献质量评估

**纳入标准**:

- 高质量随机对照试验(RCT)
- 大样本前瞻性队列研究
- 系统评价和Meta分析
- 国际权威指南和共识
- 高影响因子期刊发表文献

**证据等级**: 主要采用GRADE系统评估

### 引用格式

本文献列表采用**温哥华格式**(Vancouver Style)编排,适用于医学期刊投稿。

---

## 数据字典字段与文献对应关系

| 字段类别          | 主要参考文献编号 |
| ----------------- | ---------------- |
| 糖尿病基本信息    | [1-2]            |
| CGM核心指标       | [3, 16-27]       |
| 低血糖评估        | [14-15]          |
| 围术期血糖管理    | [4-6]            |
| 胰瘘分级          | [7, 31, 40]      |
| DGE分级           | [8, 41, 44]      |
| 术后出血          | [9, 30]          |
| Clavien-Dindo分级 | [10]             |
| 营养评估(NRS/SGA) | [11-13, 46-47]   |
| 恶病质评估        | [48-50]          |
| 胰酶替代治疗      | [13, 52-54]      |
| 肿瘤分期          | [74-75]          |
| 生活质量量表      | [75-81]          |
| 预测模型          | [64-69]          |
| 基因标志物        | [70-74]          |
| 术后功能恢复      | [82-85]          |

---

## 版权声明

本参考文献列表仅供学术研究使用。所有文献版权归原作者和出版机构所有。引用时请遵循各期刊的版权政策和学术规范。

---

**文献整理**: 医学AI团队
**审核**: 华山医院胰腺外科/内分泌科专家组
**最后更新**: 2025-10-08

---

## 附录: 推荐阅读的综述性文献

**A1.** Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. *N Engl J Med*. 2014;371(11):1039-1049.

**A2.** Dhatariya K, Corsino L, Umpierrez GE. Management of Diabetes and Hyperglycemia in Hospitalized Patients. *In: Feingold KR, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000-2023.*

**A3.** Klöppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas. *Pancreatology*. 2001;1(6):648-655.

**A4.** Aronson D, Edelman ER. Coronary artery disease and diabetes mellitus. *Cardiol Clin*. 2014;32(3):439-455.

**A5.** Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. *Nat Rev Gastroenterol Hepatol*. 2019;16(3):175-184.

---

---

*注: 文献DOI可能因出版社政策调整而变化,建议通过PubMed PMID或文章标题进行检索确认。*
